PRODUCTLIFE GROUP is an expert in the outsourced management of regulatory affairs and pharmacovigilance for the Health and Life Sciences sectors and more particularly for the pharmaceutical industry. Created 25 years ago, the Group now offers services in more than 100 countries, notably under global outsourcing agreements, with a solid and diversified base of more than 300 customer laboratories, 36 of which are in the world's Top 50.
Thanks to double-digit growth and the increase in its global outsourcing contracts, PRODUCTLIFE GROUP, which generated close to €25 million in revenue in 2018 and has a solid profitability, is expected to double over the coming years.
Advised by ADVISO PARTNERS, the shareholders are selling the majority of their shares to the investment fund 21 INVEST FRANCE. With this buyout and in order to meet the demand of its market, PRODUCTLIFE GROUP intends to expand its global coverage and accelerate its development through a strategy based on external growth, innovation and the launch of service offering in related markets such as medical devices. The management team, which has invested significantly in the transaction, fully supports this project. Pierre CUNY,
Founder and Executive Chairman of PRODUCTLIFE GROUP declares: "We are excited that a new key shareholder such as 21 Invest will become a shareholder in PRODUCTLIFE. It will actively support the group's ambitious development plan over the next few years. We thank our loyal shareholders for their unfailing trust at all times. It is a new impetus and a new era that are opening up today for PRODUCTLIFE in order to best meet the needs and requirements of its customers."
Fabrice VOITURON, Partner of 21 INVEST FRANCE adds: "PRODUCTLIFE is ideally positioned in a very buoyant market. We are delighted to support the team in the realisation of its project combining resilience, strong growth and acquisitions enabling PRODUCTLIFE to uncover its full potential and thus become essential in its market."
Marc LEBRUN, Associate Director of ADVISO PARTNERS adds: "We were very pleased to advise PRODUCTLIFE GROUP's shareholders on this transaction, which allows us to refocus the Group's shareholder structure around Management, which is the sponsor of the development project, and to give the Group a leading financial shareholder."
